Growth stocks and related exchange traded funds rallied Monday as investors shifted to a risk-on mood in response to the U.S. drug regulator granting full approval for Pfizer-BioNtech’s Covid-19 vaccine. The U.S. Food and Drug Administration has fully approved the Pfizer Inc/BioNTech SE...